NEUROLAKE
Live / Applied — Second extension granted (statement of use) (as of 09 Dec 2025)
What this means for you
Not registered yet, but its 02 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98252227
- Mark type
- Stylized text
- Filed
- 02 Nov 2023
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Danielle Rivera
Goods and services
- Class 035 — Advertising and business services: Providing an on-line searchable database featuring clinical trial data related to evaluating a pharmacodynamic biomarker for biopharmaceutical companies to assist them with drug approval for business consulting purposes; Compiling of information into computer databases; updating and maintenance of data in computer databases; Collection of quality metric information for health care providers into computer databases for business purposes; systemization of information into computer databases; Providing an internet-based database of demographic information for demographic consultation purposes
- Class 042 — Scientific and technological services: Providing an on-line searchable database featuring quality measurement data related to monitoring the safety of therapeutic products for medical practices; providing an internet-based database of quality measurement data related to monitoring the safety of therapeutic products for medical practices
- Class 044 — Medical, beauty and agricultural services: Providing an on-line searchable database featuring images of the central nervous system for medical diagnostic purposes; Providing an on-line searchable database featuring behavioral health data for medical purposes; Providing an on-line searchable database featuring medical diagnostic data in the field of central nervous system disorder information, all for diagnostic purposes; Providing an on-line searchable database featuring medical prognostic data in the field of central nervous system disorder information, all for diagnostic purposes; Providing an on-line searchable database featuring predictive medical treatment data for predictive medical diagnosis and treatment purposes; Providing an on-line searchable database featuring medical data related to monitoring the status of a medical condition for medical diagnostic and treatment purposes; Providing an on-line searchable database featuring data related to monitoring the safety of a patient during therapeutic treatment for the purpose of diagnosing medical conditions; Providing an on-line searchable database featuring medical data related to evaluating the efficacy of a therapeutic treatment for the purpose of diagnosing medical conditions; Providing an on-line searchable database featuring data related to evaluating a pharmacodynamic biomarker in clinical medical trials for the purpose of diagnosing medical conditions; Providing an on-line searchable database featuring medical data related to evaluating surrogate endpoint or reasonably likely surrogate endpoint in clinical medical trials for the purpose of diagnosing medical conditions; Providing an on-line searchable database featuring data related to evaluating the risk of developing a disorder of the nervous system for medical diagnostic purposes; Providing an on-line searchable database featuring data related to prevention of disorders of the central nervous system for medical diagnostic purposes; Providing an on-line searchable database featuring data related to medical clinical trial outcome data for medical diagnostic purposes; Providing an internet-based database of images of the central nervous system for medical diagnostic purposes; Providing an internet-based database of behavioral health data for medical purposes; Providing an internet-based database of medical diagnostic data in the field of central nervous system disorder information, all for diagnostic purposes; Providing an internet-based database of medical prognostic data in the field of central nervous system disorder information, all for medical prognostic purposes; Providing an internet-based database of medical treatment data for predictive medical diagnosis and treatment purposes; Providing an internet-based database of medical data related to monitoring the status of a medical condition for medical diagnostic and treatment purposes; providing an internet-based database of data related to monitoring the of a patient during therapeutic treatment for the purpose of diagnosing medical conditions; Providing an internet-based database of medical data related to evaluating the efficacy of a therapeutic treatment for the purpose of diagnosing medical conditions; Providing an internet-based database of data related to evaluating a pharmacodynamic biomarker in clinical medical trials for the purpose of diagnosing medical conditions; Providing an internet-based database of medical data related to evaluating surrogate endpoint or reasonably likely surrogate endpoint in clinical medical trials for the purpose of diagnosing medical conditions; Providing an internet-based database of data related to evaluating the risk of developing a disorder of the nervous system for medical diagnostic purposes; Providing an internet-based database of data related to prevention of disorders of the central nervous system for medical diagnostic purposes; Providing an internet-based database of medical clinical trial outcome data for medical diagnostic purposes
Owner
- Manifest Technologies Inc., NORTH HAVEN, CT, US
- Manifest Technologies Inc., North Haven, CT, US
Prosecution history
- 10 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Dec 2025 — SOU EXTENSION 2 GRANTED
- 09 Dec 2025 — SOU EXTENSION 2 FILED
- 09 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2025 — SOU EXTENSION 1 GRANTED
- 17 Jun 2025 — SOU EXTENSION 1 FILED
- 17 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED